Improving Services and Outcomes for Children With Autism Spectrum Disorder (ASD)
Launched by HUGO W. MOSER RESEARCH INSTITUTE AT KENNEDY KRIEGER, INC. · Feb 25, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria for Providers:
- • Providers must be employed by an Infants and Toddlers Program; and
- • Serve at least one eligible child with ASD
- Inclusion Criteria for Families/Children:
- • Children must be between 12 months, 0 days and 35 months, 30 days of age at entry into the study;
- • Children must meet criteria on the Autism Diagnostic Observation Schedule (ADOS) for ASD or autism; and
- • Caregiver and child must be available for all assessments
- Exclusion Criteria for Families/Children:
- • Children will be excluded if they are in foster care or wards of the state
- • Caregiver must be fluent in speaking and understanding the English language
About Hugo W. Moser Research Institute At Kennedy Krieger, Inc.
The Hugo W. Moser Research Institute at Kennedy Krieger, Inc. is a leading research institution dedicated to advancing the understanding and treatment of neurodevelopmental disorders. With a strong focus on innovative scientific research, the Institute fosters collaboration among experts in various fields, including neuroscience, genetics, and rehabilitation. By conducting rigorous clinical trials and studies, the Institute aims to translate findings into effective interventions that improve the quality of life for individuals with disabilities. Its commitment to excellence in research and patient care positions it as a pivotal player in the advancement of pediatric healthcare and therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Rebecca Landa, PhD, CCC-SLP
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials